Alkem Laboratories Limited

NSE: ALKEM · Healthcare · Lot size: 125

OverviewOption ChainOI AnalysisFII / DIIMax Pain

Alkem Laboratories Limited Share Price & Analysis

₹5,573.5Updated 22 Jul 2026, 03:30 pm IST
LTP
₹5,573.5
—
Open
₹5,680.5
High
₹5,680.5
Low
₹5,503
Close
₹5,681.5
52W High
₹5,934
52W Low
₹4,738
Volume
110K
Lot Size
125
Sector
Healthcare
Market Cap
₹67K Cr
Face Value
₹2
Large CapNIFTY 200NIFTY 500MIDCAP 100

Price Chart

Fundamentals

P/E
27.3
Sector P/E
54.4
P/B
4.82
EPS
₹198.32
ROE
18.9%
ROCE
21.2%
D/E Ratio
0.15
Div Yield
0.81%
Book Value
₹1,156
+

Strengths

  • ✓Strong return on equity (ROE 18.9%)
  • ✓Efficient capital deployment (ROCE 21.2%)
  • ✓Attractively valued vs sector (P/E 27.3x vs industry 54.4x)
  • ✓Low debt relative to equity (D/E 0.1x)

Peer Comparison

CompanyCMPMkt CapP/EP/BROE %ROCE %D/E
SUNPHARMA
Sun Pharmaceutical Industries Limited
₹1,944
₹4.6L Cr37.35.591620.50.07
DIVISLAB
Divi's Laboratories Limited
₹7,388
₹1.9L Cr73.411.7116.5220.01
TORNTPHARM
Torrent Pharmaceuticals Limited
₹5,040
₹1.6L Cr73.620.3227.415.20.33
APOLLOHOSP
Apollo Hospitals Enterprise Limited
₹8,939
₹1.3L Cr64.913.5622.117.90.88
CIPLA
Cipla Limited
₹1,416
₹1.1L Cr30.13.3211.615.50.01
ZYDUSLIFE
Zydus Lifesciences Limited
₹1,123
₹1.1L Cr214.1721.221.10.38
LUPIN
Lupin Limited
₹2,405
₹1.1L Cr19.64.928.729.90.32

Showing 7 peers in the same sector · Sorted by market cap

Shareholding Pattern

ALKEM · as of Mar 2026

Promoters55.13%▼0.53
FII9.40%▼0.74
DII19.42%▲1.41
Public16.05%▼0.14
CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters56.74%56.74%56.38%55.66%55.66%55.13%
FII8.49%9.11%8.69%9.02%10.14%9.40%
DII15.91%15.63%18.56%19.21%18.01%19.42%
Public18.86%18.51%16.37%16.12%16.19%16.05%

Corporate Events

Notice of meeting of the Board of Directors of Alkem Laboratories Limited ( the Company )

Board Mtg13 Aug 2026

Meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 28th May, 2026, inter alia:(i) To consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended

Dividend27 May 2026

Interim Dividend - Rs 43 Per Share

Dividend19 Feb 2026

Dividend - Rs 8 Per Share

Dividend7 Aug 2025

Interim Dividend - Rs 37 Per Share

Dividend13 Feb 2025

Dividend - Rs 5 Per Share

Record: 9 Aug 2024

Dividend8 Aug 2024

Interim Dividend - Rs 35 Per Share

Record: 16 Feb 2024

Dividend15 Feb 2024

Dividend - Rs 10 Per Share

Dividend9 Aug 2023

Latest News

All news →

Alkem Laboratories shares may react to newspaper publication

*Alkem Laboratories shares may react to newspaper publication.* The company filed a copy of a newspaper publication with the exchange, indicating a regulatory disclosure. Such filings are typically routine and part of compliance norms. No financial impact is immediately evident. 📊 *STOCKS:* ALKEM | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Regulation

NSE Filing30 Jun
Low Impact

Alkem Labs hosts investor meet for updates

*Alkem Labs hosts investor meet for updates.* The company conducted an analyst and institutional investor meet to share business updates and strategic outlook. No major announcements were disclosed. The event aims to enhance transparency ahead of upcoming earnings. 📊 *STOCKS:* ALKEM | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Earnings

NSE Filing29 Jun
Low Impact

Alkem Labs to host analyst and investor meet

*Alkem Labs to host analyst and investor meet.* The company will provide updates during the conference call. **No financial figures or major announcements** were disclosed in the filing. Event scheduled as part of regular investor outreach. 📊 *STOCKS:* ALKEM | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Earnings

NSE Filing29 Jun
Low Impact

Alkem Laboratories updates on acquisition under SEBI LODR regulations

*Alkem Laboratories updates on acquisition under SEBI LODR regulations.* The company has filed disclosures as per Regulation 30 of SEBI LODR, informing about an acquisition-related development. Details of the transaction size or target are not specified in the headline. The update is compliance-driven and lacks immediate financial metrics. 📊 *STOCKS:* ALKEM | 🏢 *SECTOR:* Regulation | #LOWIMPACT #SEBI

NSE Filing29 Jun
Low Impact

Financials

Quarterly Results

MetricDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
Revenue
₹3.7K Cr
▼6.6%
₹4.0K Cr
▲18.7%
₹3.4K Cr
▲7.2%
₹3.1K Cr
▼6.8%
₹3.4K Cr
▼1.2%
₹3.4K Cr
▲12.6%
₹3.0K Cr
▲3.3%
₹2.9K Cr
Op. Profit
₹828 Cr
▼10.1%
₹921 Cr
▲24.6%
₹739 Cr
▲89.0%
₹391 Cr
▼48.5%
₹759 Cr
▲0.8%
₹753 Cr
▲23.6%
₹609 Cr
▲51.5%
₹402 Cr
OPM
22.0%
▼4.3%
23.0%
▲4.5%
22.0%
▲83.3%
12.0%
▼47.8%
23.0%
▲4.5%
22.0%
▲10.0%
20.0%
▲42.9%
14.0%
Net Profit
₹653 Cr
▼16.2%
₹779 Cr
▲16.6%
₹668 Cr
▲107.5%
₹322 Cr
▼49.8%
₹641 Cr
▼8.7%
₹702 Cr
▲27.6%
₹550 Cr
▲80.9%
₹304 Cr
EPS (₹)
53.19
▼16.9%
63.99
▲15.2%
55.56
▲117.2%
25.58
▼51.1%
52.34
▼9.1%
57.6
▲26.3%
45.6
▲85.7%
24.55

Values in ₹ Cr · Source: Screener.in

Annual Profit & Loss

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Revenue
₹14.7K Cr
▲13.5%
₹13.0K Cr
▲2.3%
₹12.7K Cr
▲9.2%
₹11.6K Cr
▲9.1%
₹10.6K Cr
▲20.0%
₹8.9K Cr
▲6.2%
₹8.3K Cr
▲13.4%
₹7.4K Cr
▲14.9%
₹6.4K Cr
▲12.5%
₹5.7K Cr
Expenses
₹11.7K Cr
▲12.0%
₹10.5K Cr
▲0.3%
₹10.4K Cr
▲4.4%
₹10.0K Cr
▲16.3%
₹8.6K Cr
▲24.0%
₹6.9K Cr
▲0.8%
₹6.9K Cr
▲10.1%
₹6.2K Cr
▲15.7%
₹5.4K Cr
▲15.0%
₹4.7K Cr
Op. Profit
₹3.0K Cr
▲19.6%
₹2.5K Cr
▲11.7%
₹2.2K Cr
▲38.7%
₹1.6K Cr
▼21.0%
₹2.1K Cr
▲5.6%
₹1.9K Cr
▲31.8%
₹1.5K Cr
▲31.8%
₹1.1K Cr
▲11.0%
₹1.0K Cr
▲0.8%
₹1.0K Cr
OPM
20.0%
▲5.3%
19.0%
▲5.6%
18.0%
▲28.6%
14.0%
▼26.3%
19.0%
▼13.6%
22.0%
▲22.2%
18.0%
▲20.0%
15.0%
▼6.3%
16.0%
▼11.1%
18.0%
Other Income
₹409 Cr
▼17.2%
₹494 Cr
▲165.6%
₹186 Cr
▲84.2%
₹101 Cr
▼30.8%
₹146 Cr
▼36.5%
₹230 Cr
▲125.5%
₹102 Cr
▲24.4%
₹82 Cr
▼28.7%
₹115 Cr
▲4.5%
₹110 Cr
Interest
₹161 Cr
▲32.0%
₹122 Cr
▲8.9%
₹112 Cr
▲4.7%
₹107 Cr
▲105.8%
₹52 Cr
▼11.9%
₹59 Cr
▼9.2%
₹65 Cr
▲18.2%
₹55 Cr
▲0.0%
₹55 Cr
▲22.2%
₹45 Cr
Depreciation
₹382 Cr
▲7.0%
₹357 Cr
▲19.4%
₹299 Cr
▼3.5%
₹310 Cr
▲2.0%
₹304 Cr
▲10.5%
₹275 Cr
▲8.7%
₹253 Cr
▲31.1%
₹193 Cr
▲35.0%
₹143 Cr
▲41.6%
₹101 Cr
PBT
₹2.9K Cr
▲13.6%
₹2.5K Cr
▲24.9%
₹2.0K Cr
▲55.0%
₹1.3K Cr
▼29.2%
₹1.8K Cr
▲0.1%
₹1.8K Cr
▲46.2%
₹1.3K Cr
▲31.9%
₹955 Cr
▲3.1%
₹926 Cr
▼4.0%
₹965 Cr
Tax %
18.0%
▲50.0%
12.0%
▲20.0%
10.0%
▼56.5%
23.0%
▲155.6%
9.0%
▼25.0%
12.0%
▲33.3%
9.0%
▼52.6%
19.0%
▼38.7%
31.0%
▲416.7%
6.0%
Net Profit
₹2.4K Cr
▲6.1%
₹2.2K Cr
▲22.3%
₹1.8K Cr
▲79.8%
₹1.0K Cr
▼40.1%
₹1.7K Cr
▲3.8%
₹1.6K Cr
▲40.8%
₹1.1K Cr
▲48.4%
₹774 Cr
▲21.3%
₹638 Cr
▼29.5%
₹905 Cr
EPS (₹)
192.51
▲6.3%
181.11
▲20.6%
150.19
▲82.5%
82.31
▼40.2%
137.63
▲3.8%
132.57
▲40.6%
94.26
▲48.2%
63.61
▲20.5%
52.77
▼29.3%
74.61
Div Payout
28.0%
▲12.0%
25.0%
▼7.4%
27.0%
▼55.7%
61.0%
▲144.0%
25.0%
▲8.7%
23.0%
▼14.8%
27.0%
▲8.0%
25.0%
▲0.0%
25.0%
▲25.0%
20.0%

Values in ₹ Cr · Source: Screener.in

Balance Sheet

ItemSep 2025Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Liabilities
Equity Capital
₹24 Cr
▲0.0%
₹24 Cr
▲0.0%
₹24 Cr
▲0.0%
₹24 Cr
▲0.0%
₹24 Cr
▲0.0%
₹24 Cr
▲0.0%
₹24 Cr
▲0.0%
₹24 Cr
▲0.0%
₹24 Cr
▲0.0%
₹24 Cr
Reserves
₹13.3K Cr
▲11.4%
₹12.0K Cr
▲16.3%
₹10.3K Cr
▲14.0%
₹9.0K Cr
▲4.7%
₹8.6K Cr
▲17.1%
₹7.4K Cr
▲19.8%
₹6.1K Cr
▲13.3%
₹5.4K Cr
▲11.9%
₹4.8K Cr
▲8.9%
₹4.4K Cr
Borrowings
₹2.4K Cr
▲70.6%
₹1.4K Cr
▼2.6%
₹1.4K Cr
▲1.5%
₹1.4K Cr
▼47.6%
₹2.7K Cr
▲56.3%
₹1.7K Cr
▲5.6%
₹1.6K Cr
▲71.2%
₹944 Cr
▼5.4%
₹998 Cr
▲51.4%
₹659 Cr
Other Liabilities
₹4.6K Cr
▲6.0%
₹4.3K Cr
▲12.5%
₹3.8K Cr
▲16.0%
₹3.3K Cr
▲20.0%
₹2.8K Cr
▲13.5%
₹2.4K Cr
▲12.3%
₹2.2K Cr
▲18.9%
₹1.8K Cr
▲1.2%
₹1.8K Cr
▲25.2%
₹1.4K Cr
Total Liabilities
₹20.3K Cr
▲14.7%
₹17.7K Cr
▲13.6%
₹15.6K Cr
▲13.2%
₹13.8K Cr
▼2.2%
₹14.1K Cr
▲22.1%
₹11.5K Cr
▲15.8%
₹9.9K Cr
▲21.2%
₹8.2K Cr
▲7.1%
₹7.7K Cr
▲16.7%
₹6.6K Cr
Assets
Fixed Assets
₹3.3K Cr
▲16.4%
₹2.9K Cr
▼0.7%
₹2.9K Cr
▲7.1%
₹2.7K Cr
▼7.5%
₹2.9K Cr
▲3.9%
₹2.8K Cr
▼4.0%
₹2.9K Cr
▲14.9%
₹2.5K Cr
▲10.8%
₹2.3K Cr
▲27.1%
₹1.8K Cr
CWIP
₹653 Cr
▲19.2%
₹548 Cr
▲244.7%
₹159 Cr
▼50.8%
₹323 Cr
▼4.7%
₹339 Cr
▼13.7%
₹393 Cr
▲8.3%
₹363 Cr
▼26.4%
₹493 Cr
▲29.4%
₹381 Cr
▲27.4%
₹299 Cr
Investments
₹2.5K Cr
▲37.2%
₹1.8K Cr
▲281.4%
₹484 Cr
▼22.2%
₹622 Cr
▲67.7%
₹371 Cr
▲11.4%
₹333 Cr
▲27.6%
₹261 Cr
▼19.4%
₹324 Cr
▼27.0%
₹444 Cr
▼19.7%
₹553 Cr
Other Assets
₹13.8K Cr
▲10.8%
₹12.4K Cr
▲3.2%
₹12.1K Cr
▲19.1%
₹10.1K Cr
▼3.1%
₹10.5K Cr
▲30.7%
₹8.0K Cr
▲24.7%
₹6.4K Cr
▲31.9%
₹4.9K Cr
▲6.7%
₹4.6K Cr
▲16.3%
₹3.9K Cr
Total Assets
₹20.3K Cr
▲14.7%
₹17.7K Cr
▲13.6%
₹15.6K Cr
▲13.2%
₹13.8K Cr
▼2.2%
₹14.1K Cr
▲22.1%
₹11.5K Cr
▲15.8%
₹9.9K Cr
▲21.2%
₹8.2K Cr
▲7.1%
₹7.7K Cr
▲16.7%
₹6.6K Cr

Values in ₹ Cr · Source: Screener.in

Cash Flow Statement

ItemMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Operating CF
₹1.9K Cr
▼1.8%
₹1.9K Cr
▲15.8%
₹1.7K Cr
▲51.4%
₹1.1K Cr
▼12.2%
₹1.3K Cr
▲116.2%
₹585 Cr
▼25.0%
₹780 Cr
▲193.2%
₹266 Cr
▼43.5%
₹471 Cr
▼35.1%
₹726 Cr
Investing CF
₹-1.3K Cr
▼27.4%
₹-1.0K Cr
▼942.5%
₹120 Cr
▲108.4%
₹-1.4K Cr
▼44.0%
₹-995 Cr
▼35.0%
₹-737 Cr
▼131.8%
₹-318 Cr
▲9.4%
₹-351 Cr
▼19.4%
₹-294 Cr
▼243.4%
₹205 Cr
Financing CF
₹-811 Cr
▲29.2%
₹-1.1K Cr
▲35.0%
₹-1.8K Cr
▼563.4%
₹380 Cr
▲239.7%
₹-272 Cr
▼444.3%
₹79 Cr
▲120.8%
₹-379 Cr
▼545.9%
₹85 Cr
▲161.6%
₹-138 Cr
▲85.1%
₹-927 Cr
Net Cash Flow
₹-186 Cr
▲10.1%
₹-207 Cr
▼592.9%
₹42 Cr
▼27.6%
₹58 Cr
▲3000.0%
₹-2 Cr
▲97.3%
₹-73 Cr
▼189.0%
₹82 Cr
₹0 Cr
▼100.0%
₹40 Cr
▲1233.3%
₹3 Cr
Free Cash Flow
₹1.3K Cr
▼27.4%
₹1.8K Cr
▲21.2%
₹1.5K Cr
▲85.6%
₹783 Cr
▼29.8%
₹1.1K Cr
▲370.9%
₹237 Cr
▼6.3%
₹253 Cr
▲161.6%
₹-411 Cr
▼152.1%
₹-163 Cr
▼134.5%
₹472 Cr

Values in ₹ Cr · Source: Screener.in

Key Ratios History

MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Debtor Days
69d
▲6.2%
65d
▼3.0%
67d
▲3.1%
65d
▼1.5%
66d
▼8.3%
72d
▲16.1%
62d
▲0.0%
62d
▲34.8%
46d
▲9.5%
42d
Inventory Days
224d
▲13.7%
197d
▲1.5%
194d
▼26.0%
262d
▲8.7%
241d
▲21.7%
198d
▲6.5%
186d
▼15.8%
221d
▲11.6%
198d
▲17.2%
169d
Days Payable
141d
▲9.3%
129d
▲48.3%
87d
▼14.7%
102d
▼8.9%
112d
▲7.7%
104d
▼12.6%
119d
▼19.0%
147d
▲20.5%
122d
▲13.0%
108d
Cash Conv. Cycle
152d
▲15.2%
132d
▼24.1%
174d
▼22.7%
225d
▲14.8%
196d
▲17.4%
167d
▲29.5%
129d
▼4.4%
135d
▲10.7%
122d
▲18.4%
103d
Working Capital Days
124d
▼8.1%
135d
▲104.5%
66d
▲112.9%
31d
▼35.4%
48d
▲9.1%
44d
▼20.0%
55d
▲37.5%
40d
▲17.6%
34d
▲161.5%
13d
ROCE
20.0%
▲0.0%
20.0%
▲42.9%
14.0%
▼22.2%
18.0%
▼18.2%
22.0%
▲22.2%
18.0%
▲12.5%
16.0%
▼5.9%
17.0%
▼19.0%
21.0%
▼8.7%
23.0%

Source: Screener.in · Lower days = better efficiency

Deep Dive Analysis

Option Chain
Strike-wise OI & IV
OI Analysis
PCR, buildup type
FII / DII
Institutional flows
Max Pain
Writer pain levels

About Alkem Laboratories Limited

Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.(Source : 202003-01 Annual Report Page No:107)

Healthcare · Pharmaceuticals & Biotechnology

Related Analysis

Same Sector

APOLLOHOSP
Apollo Hospitals Enterprise Limited
Neutral
AUROPHARMA
Aurobindo Pharma Limited
Neutral
BIOCON
Biocon Limited
Neutral
CIPLA
Cipla Limited
Neutral
DIVISLAB
Divi's Laboratories Limited
Neutral

Frequently Asked Questions

What is Alkem Laboratories Limited share price today?▾
Alkem Laboratories Limited (ALKEM) is currently trading at ₹5,573.5 on NSE, as of the last market session. Prices update daily after market close on MarketNetra.
Is Alkem Laboratories Limited available in F&O (Futures & Options)?▾
Yes, Alkem Laboratories Limited (ALKEM) is part of the NSE F&O segment with a lot size of 125 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Alkem Laboratories Limited 52-week high and low?▾
Alkem Laboratories Limited's 52-week high is ₹5,934 and the 52-week low is ₹4,738. The current price of ₹5,573.5 is 6.1% below the 52W high.
What is Alkem Laboratories Limited P/E ratio?▾
Alkem Laboratories Limited's current P/E ratio is 27.3. This indicates the market is paying ₹27.3 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Alkem Laboratories Limited options?▾
Alkem Laboratories Limited options are traded on NSE with monthly expiry contracts (lot size: 125 shares). To trade ALKEM options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.